BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1081730)

  • 1. Evidence for complement activation by the alternate pathway in the arthritis of hypogammaglobulinemic patients.
    Munthe E; Hoyeraal HM; Froland SS; Mellbye OJ; Kåss E; Natvig JB
    Rheumatology; 1975; 6():43-51. PubMed ID: 1081730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of complement components C3 and factor B in synovial fluids.
    Hunder GG; McDuffie FC; Mullen BJ
    J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The complement system].
    Lambert PH
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG; McDuffie FC; Clark RJ
    J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K; Schur PH; Ruddy S
    J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The C'-3 constituent of the complement and rheumatoid factors in serum-synovial fluid paris in progressive polyarthritis and reactive synovites due to local causes (author's transl)].
    Hrncír Z; Tichý M; Salavec M; Vavrina J
    Cas Lek Cesk; 1976 Dec; 115(48):1487-90. PubMed ID: 1000565
    [No Abstract]   [Full Text] [Related]  

  • 9. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
    Ruddy S; Fearon DT; Austen KF
    Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid synovitis: complement and immune complexes.
    Schur PH; Britton MC; Franco AE; Corson JM; Sosman JL; Ruddy S
    Rheumatology; 1975; 6():34-42. PubMed ID: 1202605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
    Perrin LH; Shiraishi S; Stroud RM; Lambert PH
    J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the synovial membrane in early diagnosed cases of rheumatoid arthritis. II. Immunohistochemical and serological studies].
    Emmrich J; Geiler G
    Z Rheumatol; 1980; 39(5-6):157-69. PubMed ID: 7415585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C4 component of complement, rheumatoid factors and circulating immunocomplexes in rheumatoid-arthritis and reactive synovitides of local origin; serum synovial fluid].
    Hrncír Z; Tichý M; Salavec M; Vavrina J
    Cas Lek Cesk; 1978 Dec; 117(49):1526-9. PubMed ID: 737699
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins and complement components in synovial fluid of patients with acute rheumatic fever.
    Svartman M; Potter EV; Poon-King T; Earle DP
    J Clin Invest; 1975 Jul; 56(1):111-7. PubMed ID: 1141429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
    Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
    Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immune parameters of synovial fluid and blood in rheumatoid arthritis.
    Dorwart BB; Hebert J; Schumacher HR; Abdou NI
    J Rheumatol; 1975 Dec; 2(4):363-72. PubMed ID: 1082030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.